医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.

广告
第一作者: Michelino,De Laurentiis
第一单位: Division of Breast Medical Oncology, Department of Breast and Thoracic Oncology Director, Istituto Nazionale Tumori IRCCS "Fondazione Pascale", Napoli, Italy. m.delaurentiis@istitutotumori.na.it.
作者单位: Division of Breast Medical Oncology, Department of Breast and Thoracic Oncology Director, Istituto Nazionale Tumori IRCCS "Fondazione Pascale", Napoli, Italy. m.delaurentiis@istitutotumori.na.it. [1] Institute of Oncology Ljubljana, Ljubljana, Slovenia. [2] Western Cancer Institute, Nantes, France. [3] Sunnybrook Health Sciences Centre, Toronto, ON, Canada. [4] Virgen del Rocío University Hospital, Biomedicine Institute, Seville, Spain. [5] Montpellier Cancer Institute, Montpellier, France. [6] The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.;Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA. [7] Gregorio Marañón General University Hospital, GEICAM, Universidad Complutense, CIBERONC, Madrid, Spain. [8] Royal Marsden Hospital NHS Foundation Trust, Sutton, UK. [9] Curie Institute, Paris, France. [10] USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA. [11] University Hospital 12 de Octubre, Clara Campal Comprehensive Cancer Center (HM CIOCC), Madrid, Spain. [12] Faculty of Medicine, Cairo University, Cairo, Egypt. [13] Tata Medical Center, Kolkata, India. [14] Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. [15] Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italia. [16]
DOI 10.1007/s10549-021-06374-6
PMID 34625861
发布时间 2022-01-27
提交
  • 浏览1
Breast cancer research and treatment

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷